Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CDNA | Common Stock | Options Exercise | $610 | +500 | +0.82% | $1.22* | 61.8K | Feb 9, 2022 | Direct | F1 |
transaction | CDNA | Common Stock | Sale | -$21.5K | -500 | -0.81% | $42.96 | 61.3K | Feb 9, 2022 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CDNA | Stock Option (right to buy) | Options Exercise | $0 | -500 | -3.85% | $0.00 | 12.5K | Feb 9, 2022 | Common Stock | 500 | $1.22 | Direct | F1, F2 |
Id | Content |
---|---|
F1 | The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. |
F2 | 1/12th of the shares subject to the option vested on August 13, 2017 and the shares subject to the option vested monthly thereafter through July 13, 2018. |